Company Filing History:
Years Active: 2021
Title: Gwenda Ligon: Innovator in Anti-ALK Antibodies
Introduction
Gwenda Ligon is a prominent inventor based in Hamden, CT (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors involved in various disorders.
Latest Patents
Gwenda Ligon holds a patent for "Anti-ALK antibodies and methods for use thereof." This patent involves compositions, methods, and uses of antibodies that specifically bind to ALK, a receptor tyrosine kinase. The invention aims to modulate the expression and/or activity of ALK, providing potential treatments for disorders such as cancer.
Career Highlights
Ligon is associated with Celldex Therapeutics Limited, where she applies her expertise in antibody development. Her work focuses on innovative solutions for managing serious health conditions, showcasing her commitment to advancing medical science.
Collaborations
Some of her notable coworkers include Diego Alvarado and Jay Lillquist, who contribute to the collaborative environment at Celldex Therapeutics Limited.
Conclusion
Gwenda Ligon's work in developing anti-ALK antibodies represents a significant advancement in therapeutic options for cancer treatment. Her innovative spirit and dedication to research continue to inspire progress in the field of biotechnology.